Back to BlackRock, Inc.

CLDX
6 quarters

Position history for BlackRock, Inc.'s holdings in CELLDEX THERAPEUTICS INC NEW

BlackRock, Inc. holds 5.4M shares of CLDX (CELLDEX THERAPEUTICS INC NEW), worth $170.3M as of 2026-Q1. The position was decreased (-1.5% shares). CLDX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$170.3M

Current Shares

5.4M

Total Value Change

+$31.8M

Total Shares Change

-110,785

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
5.4M
-1.5%
$170.3M0.0%$28.94
0
2025-Q4
Decreased
5.5M
-1.0%
$148.1M0.0%$26.43
0
2025-Q3
Decreased
5.5M
-0.8%
$142.4M0.0%$26.19
0
2025-Q2
Increased
5.6M
+0.5%
$112.9M0.0%$20.29
30
2025-Q1
Increased
5.5M
+0.8%
$100.3M0.0%$19.93
30
2024-Q4
New
5.5M
-
$138.5M0.0%$25.12
42

Other major holders of CLDX: WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used